Location History:
- Swedesburg, PA (US) (1996)
- Meriden, CT (US) (2001 - 2014)
- Meriden, CO (US) (2016)
Company Filing History:
16 out of 3,684 
3 out of 2,198 Years Active: 1996-2016
Title: **Margaret E Sorenson: Innovator in HIV Research and Treatment**
Introduction
Margaret E Sorenson is a notable inventor located in Meriden, CT, whose contributions to the field of HIV research have led to 19 patents. Her innovative work has significantly advanced the understanding and treatment of human immunodeficiency virus (HIV), proving vital in the fight against this global health crisis.
Latest Patents
Sorenson's latest patents highlight her dedication to developing effective therapies for HIV. One of her significant inventions is the patent for "Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication." This patent discloses compounds that serve as novel inhibitors of HIV, along with pharmaceutical compositions and methods for treating HIV infections.
In addition to this, she holds a patent for "HIV integrase inhibitors," which details compounds that inhibit the HIV integrase enzyme. By preventing viral integration into human DNA, these compounds present a promising avenue for treating individuals infected with HIV and AIDS. Both patents underscore her vital role in advancing pharmaceutical strategies against this virus.
Career Highlights
Throughout her career, Margaret E Sorenson has worked with reputable organizations in the pharmaceutical industry, including Bristol-Myers Squibb Company and SmithKline Beecham Corporation. Her tenure at these companies has allowed her to collaborate on important research projects focused on developing novel antiviral agents.
Collaborations
Collaboration has been a cornerstone of Sorenson's work, exemplified by her partnerships with esteemed colleagues such as B Narasimhulu Naidu and Michael A Walker. These collaborations have facilitated the exchange of ideas and expertise that have ultimately driven innovation in HIV therapies.
Conclusion
Margaret E Sorenson stands out as a pioneering inventor in the field of HIV treatment and research. Her 19 patents reflect her commitment to improving therapeutic options for those affected by HIV. Through her collaborations and career achievements, Sorenson continues to make a significant impact in the pharmaceutical industry, paving the way for future innovations in viral infection treatment.